Chenevas-Paule Q, Trilling B, Sage P Y, Girard E, Faucheron J L
Colorectal Unit, Department of Surgery, Michallon University Hospital, 38000, Grenoble, France.
University Grenoble Alps, UMR 5525, CNRS, TIMC-IMAG, 38000, Grenoble, France.
Tech Coloproctol. 2020 Jan;24(1):41-48. doi: 10.1007/s10151-019-02126-3. Epub 2019 Dec 13.
There is ongoing debate regarding surgical treatment of splenic flexure cancer. The main points of controversy include the appropriate extent of colon resection, either to the right or to the left, and the appropriate extent of lymph-node dissection. The aim of this study was to review our experience in laparoscopic treatment of splenic flexure cancer cases and to compare our data to the recent literature.
Consecutive patients, operated on for splenic flexure colon carcinoma at a single institution between April 2005 and January 2013, were included in the study. Exclusion criteria were a previous history of colorectal cancer, recurrent colonic cancer, emergency cases with an obstructive tumor or a perforated tumor with peritonitis, synchronous cancer, palliative surgery, and a past history of colorectal resection. Patients underwent laparoscopic segmental left colectomy with ligation of the left branch of the middle colic and of the left colic artery. Patient characteristics, operative and postoperative outcomes, and long-term technical, functional, and oncological results from a prospectively maintained database were retrospectively analyzed. After hospital discharge, standardized follow-up was performed at 1 month postoperatively, then every 3 months during the first 2 years, and every 6 months thereafter, for a total of 5 years.
A total of 28 consecutive patients (16 males) with a median age of 71.8 years (range 42.5-88.8 years) were included. Ninety-day mortality was 3.5% and surgical morbidity was 21.5% with anastomotic leak rate of 10.7%. All survivors experienced good or very good functional results. During a median follow-up period of 50.9 months, eight patients (28.5%) presented with a recurrence. The 5-year overall and disease-free survival rates were 46.3% and 39.2%, respectively.
Segmental left colectomy for splenic flexure carcinoma is associated with reasonably low morbidity and very good functional results. However, survival rates are low.
关于脾曲癌的手术治疗一直存在争议。主要争议点包括结肠切除的合适范围,是向右还是向左,以及淋巴结清扫的合适范围。本研究的目的是回顾我们在腹腔镜治疗脾曲癌病例方面的经验,并将我们的数据与近期文献进行比较。
本研究纳入了2005年4月至2013年1月在单一机构接受脾曲结肠癌手术的连续患者。排除标准为既往有结直肠癌病史、复发性结肠癌、伴有梗阻性肿瘤的急诊病例或伴有腹膜炎的穿孔性肿瘤、同时性癌、姑息性手术以及既往有结直肠切除术病史。患者接受腹腔镜左半结肠切除术,结扎中结肠左支和左结肠动脉。对前瞻性维护数据库中的患者特征、手术和术后结果以及长期技术、功能和肿瘤学结果进行回顾性分析。出院后,术后1个月进行标准化随访,然后在头2年每3个月随访一次,此后每6个月随访一次,共5年。
共纳入28例连续患者(16例男性),中位年龄71.8岁(范围42.5 - 88.8岁)。90天死亡率为3.5%,手术并发症发生率为21.5%,吻合口漏发生率为10.7%。所有幸存者的功能结果良好或非常好。在中位随访期50.9个月期间,8例患者(28.5%)出现复发。5年总生存率和无病生存率分别为46.3%和39.2%。
脾曲癌的左半结肠切除术并发症发生率较低,功能结果非常好。然而,生存率较低。